Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10216-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10216-1-AP, RRID:AB_2269231
- Product name
- Chemerin antibody
- Antibody type
- Polyclonal
- Description
- Chemerin antibody (Cat. #10216-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, Mouse and has been validated for the following applications: IHC, WB, ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Multi-omic analysis reveals retinoic acid molecular drivers for dermal fibrosis and regenerative repair in the skin.
Loss of chemerin prevents ovariectomy-induced osteoporosis in mice through intraosseous vascular remodeling.
Molecular dynamics of chemotactic signalling orchestrates dental pulp stem cell fibrosis during aging.
Assessing personalized molecular portraits underlying endothelial-to-mesenchymal transition within pulmonary arterial hypertension.
Targeting copper death genotyping associated gene RARRES2 suppresses glioblastoma progression and macrophages infiltration.
RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer.
Targeting the chemerin/CMKLR1 axis by small molecule antagonist α-NETA mitigates endometriosis progression.
Neutrophils Promote Tumor Progression in Oral Squamous Cell Carcinoma by Regulating EMT and JAK2/STAT3 Signaling Through Chemerin.
Silencing of DsbA-L gene impairs the PPARγ agonist function of improving insulin resistance in a high-glucose cell model.
Griffin M, Guo JL, Parker JBL, Kuhnert M, Li DJ, Valencia C, Morgan A, Downer M, Cotterell AC, Lu JM, Dilorio S, Bauer-Rowe Ramos KE, Januszyk M, Chang HY, Wan DC, Longaker MT
Cell stem cell 2025 Sep 4;32(9):1421-1437.e6
Cell stem cell 2025 Sep 4;32(9):1421-1437.e6
Loss of chemerin prevents ovariectomy-induced osteoporosis in mice through intraosseous vascular remodeling.
Wang B, Ni J, Yu L, Chen S, Shang W, Fang P, Min W
Molecular and cellular endocrinology 2025 Apr 1;599:112465
Molecular and cellular endocrinology 2025 Apr 1;599:112465
Molecular dynamics of chemotactic signalling orchestrates dental pulp stem cell fibrosis during aging.
Sun T, Zhong Q, Yu X, Luo H, Ren F, Liu C, Chen P, Flores-Borja F, Sun H, An Z
Frontiers in cell and developmental biology 2024;12:1530644
Frontiers in cell and developmental biology 2024;12:1530644
Assessing personalized molecular portraits underlying endothelial-to-mesenchymal transition within pulmonary arterial hypertension.
Wu R, Zhang G, Guo M, Li Y, Qin L, Jiang T, Li P, Wang Y, Wang K, Liu Y, He Z, Cheng Z
Molecular medicine (Cambridge, Mass.) 2024 Oct 26;30(1):189
Molecular medicine (Cambridge, Mass.) 2024 Oct 26;30(1):189
Targeting copper death genotyping associated gene RARRES2 suppresses glioblastoma progression and macrophages infiltration.
Yan T, Yang H, Meng Y, Li H, Jiang Q, Liu J, Xu C, Xue Y, Xu J, Song Y, Chu X, Wang L, Chen X, Che F
Cancer cell international 2023 May 29;23(1):105
Cancer cell international 2023 May 29;23(1):105
RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer.
Li YQ, Sun FZ, Li CX, Mo HN, Zhou YT, Lv D, Zhai JT, Qian HL, Ma F
Military Medical Research 2023 Jul 25;10(1):34
Military Medical Research 2023 Jul 25;10(1):34
Targeting the chemerin/CMKLR1 axis by small molecule antagonist α-NETA mitigates endometriosis progression.
Yu M, Yang Y, Zhao H, Li M, Chen J, Wang B, Xiao T, Huang C, Zhao H, Zhou W, Zhang JV
Frontiers in pharmacology 2022;13:985618
Frontiers in pharmacology 2022;13:985618
Neutrophils Promote Tumor Progression in Oral Squamous Cell Carcinoma by Regulating EMT and JAK2/STAT3 Signaling Through Chemerin.
Hu X, Xiang F, Feng Y, Gao F, Ge S, Wang C, Zhang X, Wang N
Frontiers in oncology 2022;12:812044
Frontiers in oncology 2022;12:812044
Silencing of DsbA-L gene impairs the PPARγ agonist function of improving insulin resistance in a high-glucose cell model.
Zhou X, Li JQ, Wei LJ, He MZ, Jia J, Zhang JY, Wang SS, Feng L
Journal of Zhejiang University. Science. B 2020 Dec.;21(12):990-998
Journal of Zhejiang University. Science. B 2020 Dec.;21(12):990-998
No comments: Submit comment
No validations: Submit validation data